AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2022

May 18, 2022

3695_dirs_2022-05-18_27033333-c543-4896-8d43-802311c12395.html

Director's Dealing

Opens in your device viewer

Mandatory notification of acquisition of shares by primary insider

Oslo, Norway, May 18, 2022 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics AS, has today acquired 10,000 shares in Nykode Therapeutics AS at a price of NOK 32.05 per share. Following the transaction, Martin Nicklasson holds 32,000 shares in Nykode Therapeutics AS.

Please see further details in the attached document.

AI assistant

Nykode Therapeutics ASA — Director's Dealing 2022

3695_dirs_2022-05-18_27033333-c543-4896-8d43-802311c12395.html

Mandatory notification of acquisition of shares by primary insider

More from Nykode Therapeutics ASA

Nykode Therapeutics ASA Director's Dealing 2022